Literature DB >> 26107486

Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts.

Kshitij Gupta1, Stephanie J Mattingly2, Ralph J Knipp2, Kirill A Afonin1,3, Mathias Viard4,5, Joseph T Bergman1, Marissa Stepler1, Michael H Nantz2, Anu Puri1, Bruce A Shapiro1.   

Abstract

AIM: To evaluate the structure-activity relationship of oxime ether lipids (OELs) containing modifications in the hydrophobic domains (chain length, degree of unsaturation) and hydrophilic head groups (polar domain hydroxyl groups) toward complex formation with siRNA molecules and siRNA delivery efficiency of resulting complexes to a human breast cancer cell line (MDA-MB-231). MATERIALS &
METHODS: Ability of lipoplex formation between oxime ether lipids with nucleic acids were examined using biophysical techniques. The potential of OELs to deliver nucleic acids and silence green fluorescent protein (GFP) gene was analyzed using MDA-MB-231 and MDA-MB-231/GFP cells, respectively. RESULTS &
CONCLUSION: Introduction of hydroxyl groups to the polar domain of the OELs and unsaturation into the hydrophobic domain favor higher transfection and gene silencing in a cell culture system.

Entities:  

Keywords:  RNA interference; breast cancer cells; lipoplexes; nonsymmetric hydrophobic domain; oxime ether lipids; structure–activity relationship

Mesh:

Substances:

Year:  2015        PMID: 26107486      PMCID: PMC4636123          DOI: 10.2217/nnm.15.105

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  48 in total

1.  In vitro lipofection with novel asymmetric series of 1,2-dialkoylamidopropane-based cytofectins containing single symmetric bis-(2-dimethylaminoethane) polar headgroups.

Authors:  Michalakis Savva; Pensung Chen; Ahmad Aljaberi; Bilge Selvi; Michael Spelios
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

2.  Fluorescence anisotropy: analysis of tRNA binding to the T box riboswitch antiterminator RNA.

Authors:  S Zhou; R Anupam; J V Hines
Journal:  Methods Mol Biol       Date:  2015

3.  Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles.

Authors:  R Leventis; J R Silvius
Journal:  Biochim Biophys Acta       Date:  1990-03-30

4.  Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity.

Authors:  M J Bennett; A M Aberle; R P Balasubramaniam; J G Malone; R W Malone; M H Nantz
Journal:  J Med Chem       Date:  1997-12-05       Impact factor: 7.446

Review 5.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

6.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

Authors:  Sebastien Spagnou; Andrew D Miller; Michael Keller
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

7.  Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery.

Authors:  Mukthavaram Rajesh; Joyeeta Sen; Marepally Srujan; Koushik Mukherjee; Bojja Sreedhar; Arabinda Chaudhuri
Journal:  J Am Chem Soc       Date:  2007-08-25       Impact factor: 15.419

Review 8.  Structure and kinetics of lipid-nucleic acid complexes.

Authors:  Nily Dan; Dganit Danino
Journal:  Adv Colloid Interface Sci       Date:  2014-01-28       Impact factor: 12.984

9.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Authors:  Charles N Landen; Arturo Chavez-Reyes; Corazon Bucana; Rosemarie Schmandt; Michael T Deavers; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

10.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

View more
  8 in total

1.  Challenges to optimizing RNA nanostructures for large scale production and controlled therapeutic properties.

Authors:  Morgan Chandler; Martin Panigaj; Lewis A Rolband; Kirill A Afonin
Journal:  Nanomedicine (Lond)       Date:  2020-05-26       Impact factor: 5.307

2.  Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAi.

Authors:  Nadia R Ayat; Zhanhu Sun; Da Sun; Michelle Yin; Ryan C Hall; Amita M Vaidya; Xujie Liu; Andrew L Schilb; Josef H Scheidt; Zheng-Rong Lu
Journal:  Nucleic Acid Ther       Date:  2019-05-28       Impact factor: 5.486

3.  Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts.

Authors:  Anu Puri; Faisal Ibrahim; André O'Reilly Beringhs; Camryn Isemann; Paul Zakrevsky; Abigail Whittenburg; Derek Hargrove; Tapan Kanai; Rebecca S Dillard; Natalia de Val; Michael H Nantz; Xiuling Lu; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2022-06-04       Impact factor: 6.096

4.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

Review 5.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

6.  Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells.

Authors:  Anu Puri; Mathias Viard; Paul Zakrevsky; Serena Zampino; Arabella Chen; Camryn Isemann; Sohaib Alvi; Jeff Clogston; Upendra Chitgupi; Jonathan F Lovell; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2020-03-06       Impact factor: 5.307

Review 7.  Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.

Authors:  M Brittany Johnson; Morgan Chandler; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-04-20       Impact factor: 17.873

Review 8.  Small-Angle Scattering as a Structural Probe for Nucleic Acid Nanoparticles (NANPs) in a Dynamic Solution Environment.

Authors:  Ryan C Oliver; Lewis A Rolband; Alanna M Hutchinson-Lundy; Kirill A Afonin; Joanna K Krueger
Journal:  Nanomaterials (Basel)       Date:  2019-05-02       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.